Pesquisar
Molecular Partners AG
MOLNAdicionar à lista de desejos
3.980USD
+0.050+1.27%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
149.29MValor de mercado
PerdaP/L TTM
Mais detalhes de Molecular Partners AG Empresa
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Informações de Molecular Partners AG
Código da empresaMOLN
Nome da EmpresaMolecular Partners AG
Data de listagemOct 22, 2014
CEOAmstutz (Patrick)
Número de funcionários159
Tipo de títulosDepository Receipt
Fim do ano fiscalOct 22
EndereçoWagistrasse 14
CidadeSCHLIEREN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSwitzerland
Código postal8952
Telefone41447557700
Sitehttps://www.molecularpartners.com/
Código da empresaMOLN
Data de listagemOct 22, 2014
CEOAmstutz (Patrick)
Executivos da empresa Molecular Partners AG
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Steven H. (Steve) Holtzman, Ph.D.
Mr. Steven H. (Steve) Holtzman, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Vito J. Palombella, Ph.D.
Dr. Vito J. Palombella, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Michael Vasconcelles, M.D.
Dr. Michael Vasconcelles, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Agnete B. Fredriksen, Ph.D.
Dr. Agnete B. Fredriksen, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Dominik Hoechli, M.D.
Dr. Dominik Hoechli, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Michael Tobias Stumpp, Ph.D.
Dr. Michael Tobias Stumpp, Ph.D.
Executive Vice President - Projects, Member of the Management Board
Executive Vice President - Projects, Member of the Management Board
--
--
Dr. Patrick Amstutz, Ph.D.
Dr. Patrick Amstutz, Ph.D.
Chief Executive Officer, Executive Director, Member of the Management Board
Chief Executive Officer, Executive Director, Member of the Management Board
--
--
Mr. Steven H. (Steve) Holtzman, Ph.D.
Mr. Steven H. (Steve) Holtzman, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. William M. (Bill) Burns
Mr. William M. (Bill) Burns
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Seth D. Lewis
Mr. Seth D. Lewis
Senior Vice President - Investor Relations and Strategy
Senior Vice President - Investor Relations and Strategy
--
--
Mr. Sandip S. Kapadia, CPA
Mr. Sandip S. Kapadia, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Molecular Partners AG?
Os cinco principais acionistas de Molecular Partners AG são: Dr. Michael Tobias Stumpp, Ph.D.
Quantas instituições possuem ações da Molecular Partners AG (MOLN)?
Em 2026Q1, 14 instituições possuíam ações da Molecular Partners AG, com valor de mercado aproximado de 3.59M, representando 9.60% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -12188.00.